Novo Nordisk (NVO) valuation
Run six valuation models on Novo Nordisk with live data: DCF, Reverse DCF, Graham number, Monte Carlo, scenarios and sum-of-the-parts (NAV).
Novo Nordisk
NVO · Healthcare
Current price
46,25 DKK
You're trying every model for free, no account needed. Sign up to save your analyses →
Valuation
- Market cap
- DKK 202.61B
- PE (TTM | NTM | +1y)
- 11.39 | 13.79 | 2.13
- Price / Sales
- 0.62
- EV / EBITDA
- 1.75
- Price / Book
- 6.60
Cash flow
- FCF yield(11.39 / 46.24)
- +24.64%
- SBC-adjusted FCF yield
- —
- SBC impact
- —
Margins & growth
- Profit margin
- +35.35%
- Operating margin
- +42.54%
- Quarterly earnings (YoY)
- -20.81%
- Quarterly revenue (YoY)
- +2.12%
Balance
- Cash
- DKK 44.98B
- Debt
- DKK 140.13B
- Net position
- -DKK 95.14B
Dividend
- Dividend yield
- +3.81%
- Payout ratio
- +44.46%
- Next payout
- 8/25/2026
Price (1 year)
-11.76%Revenue
estimate
EBITDA
Net income
Free cash flow
EPS
estimate
Cash & debt
CashDebt
Return of capital
DividendsBuybacks
Shares outstanding
Operating expenses
R&DSG&A
Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.